https://www.businesswire.com/news/home/20210111006077/en/AvantGen-Announces-Licensing-of-Its-Anti-SARS-CoV-2-Antibodies-to-IGM-Biosciences-for-COVID-19-Therapy-Development
AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19...
AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cel...